Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

BMC Cancer

Table 1 Sample descriptive statistics

	n	*Mean or %*	Sd	*Min*	*Max*
Baseline age (yrs)	602	53.6	10.5	27	89
EQ-5D	3766	0.715	0.263	−0.594	1
Global health status/QoL	3816	61.85	22.82	0	100
Physical Function	3817	76.74	21.98	0	100
Role Function	3817	70.84	29.47	0	100
Emotional Function	3817	74.67	22.99	0	100
Cognitive Function	3817	81.01	21.94	0	100
Social Function	3817	74.14	28.38	0	100
Fatigue	3817	35.67	25.65	0	100
Nausea / vomiting	3817	7.47	14.72	0	100
Pain	3817	27.32	27.49	0	100
Dyspnoea	3817	18.3	25.75	0	100
Insomnia	3817	27.05	28.85	0	100
Appetite loss	3817	16.77	26.39	0	100
Constipation	3817	19.53	27.56	0	100
Diarrhoea	3817	6.58	16.65	0	100
Financial problems	3817	21.47	31.37	0	100
*Sex - female*	598	99.34
*Baseline Disease Stage*
Stage 0	6	1.02
Stage I	70	11.93
Stage IIA	103	17.55
Stage IIB	81	13.8
Stage IIIA	111	18.91
Stage IIIB	58	9.88
Stage IIIC	41	6.98
Stage IV	117	19.93

ISSN: 1471-2407